Oaktree Acquisition Corporation. III Life Sciences

OACC

Financials

10-QQ2 ended 06/30/2608/12/2610-QQ1 ended 03/31/2605/13/2610-KFY 202503/26/2610-QQ3 ended 09/30/2511/13/2510-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report10/26/268-KCurrent report10/16/268-KCurrent report10/15/268-KCurrent report10/29/258-KCurrent report10/17/25

Prospectuses and Registrations

424B4Prospectus10/24/24S-1/ARegistration statement (amended)10/18/24S-1Registration statement (IPO)10/04/24

Proxies

DEFA14AAdditional proxy materials10/16/26DEFA14AAdditional proxy materials10/15/26DEF 14ADefinitive proxy10/02/26PRE 14APreliminary proxy09/21/26

Ownership

Form 4Insider transaction10/23/26SC 13GBeneficial ownership08/14/26SC 13GBeneficial ownership05/15/26Form 3Initial insider ownership10/29/25Form 3Initial insider ownership10/22/25

Other

CERTCEO/CFO certification10/24/248-A12B8-A12B10/23/24EFFECTRequest for effectiveness10/23/24CORRESPCorrespondence with the SEC10/21/24CORRESPCorrespondence with the SEC10/21/24